(Q44728957)

5 December 2017

title

A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension (English)

1 reference

5 December 2017

0 references

Jan N Basile

1

1 reference

5 December 2017

Daniel T Lackland

2

1 reference

5 December 2017

Jeffrey M Basile

3

1 reference

5 December 2017

Jessica E Riehle

4

1 reference

5 December 2017

Brent M Egan

5

1 reference

5 December 2017

publication date

1 January 2004

1 reference

Journal of Clinical Hypertension

5 December 2017

published in

1 reference

5 December 2017

volume

6

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

18-25

1 reference

Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

A practical approach to achieving recommended blood pressure goals in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Modification of high blood pressure after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Optimizing the use of beta-blockers in the effective treatment and management of heart failure: a case study approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Attitudes of primary care providers toward diabetes: barriers to guideline implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Why don't physicians follow clinical practice guidelines? A framework for improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

A user's manual for the IOM's 'Quality Chasm' report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Changes in the phamacologic treatment of hypertension in the Department of Veterans Affairs 1997-1999: decreased use of calcium antagonists and increased use of beta-blockers and thiazide diuretics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Implications of a health lifestyle and medication analysis for improving hypertension control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Goal-oriented hypertension management: translating clinical trials to practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.02665.X

10.1111/J.1524-6175.2004.02665.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference